Trustworthy

At ClinicAL™, we understand that hedge funds, private equity firms, and institutional research teams need complete confidence in the data guiding their investment strategies. Our compliance framework is built to meet the highest standards of integrity—ensuring every insight we deliver is actionable, auditable, and ethically sourced.

• Public, Proprietary, and Non-NDA Data Only: We rely solely on public sources (e.g., ClinicalTrials.gov, PubMed), proprietary analytics developed from Edwards-Hunt Group’s 25-year clinical operations experience, and other non-NDA datasets. This eliminates the risk of breaching confidentiality or accessing protected health information (PHI).

• Independent Operations: ClinicAL™ operates as a distinct division of SAB Capital Group, LLC, and maintains full operational separation from Edwards-Hunt Group (EHG). We do not access EHG’s confidential or client-protected data—preserving compliance with all NDAs and reinforcing client trust.

• Audit Trails for Transparency: Every dataset, model, and investor briefing is supported by clear audit trails, allowing verification of data sources and analytical integrity. This transparency supports both internal compliance processes and external regulatory scrutiny.

• NDA-Compliant Briefings: For executive briefings or custom analyses, we operate under secure NDAs when required—ensuring your investment theses, strategies, or trial-specific concerns remain protected.

• Regulatory Alignment: Our operations comply with all relevant data privacy regulations and financial industry standards, offering confidence to funds navigating complex bioscience investments.

Why It Matters

Whether you're managing a biotech-heavy hedge fund portfolio, conducting diligence for a PE acquisition, or generating institutional research, ClinicAL™ provides clinical intelligence you can trust—without legal or ethical exposure.